{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:10:08Z","timestamp":1782990608279,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1007\/s11892-005-0007-2","type":"journal-article","created":{"date-parts":[[2007,5,22]],"date-time":"2007-05-22T22:45:57Z","timestamp":1179873957000},"page":"184-188","source":"Crossref","is-referenced-by-count":21,"title":["Is aggregated IAPP a cause of beta-cell failure in transplanted human pancreatic islets?"],"prefix":"10.1007","volume":"5","author":[{"given":"Per","family":"Westermark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunilla T.","family":"Westermark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"7_CR1","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1210\/jc.2004-0405","volume":"89","author":"RL Hull","year":"2004","unstructured":"Hull RL, Westermark GT, Westermark P, Kahn SE: Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab 2004, 89:3629\u20133643. State-of-the-art article on the importance of IAPP aggregation for the \u00e2-cell failure in type 2 diabetes.","journal-title":"J Clin Endocrinol Metab"},{"key":"7_CR2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0959-440X(99)00049-4","volume":"10","author":"JC Rochet","year":"2000","unstructured":"Rochet JC, Lansbury PTJ: Amyloid fibrillogenesis: themes and variations. Curr Opin Struct Biol 2000, 10:60\u201368.","journal-title":"Curr Opin Struct Biol"},{"key":"7_CR3","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed R, Head E, Thompson JL, et al.: Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003, 300:486\u2013489. For those who want to get information as to why proteins aggregate into amyloid and how aggregates exert their toxicity.","journal-title":"Science"},{"key":"7_CR4","doi-asserted-by":"crossref","first-page":"46363","DOI":"10.1074\/jbc.C400260200","volume":"279","author":"R Kayed","year":"2004","unstructured":"Kayed R, Sokolov Y, Edmonds B, et al.: Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J Biol Chem 2004, 279:46363\u201346366.","journal-title":"J Biol Chem"},{"key":"7_CR5","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/35037739","volume":"407","author":"J Yuan","year":"2000","unstructured":"Yuan J, Yankner BA: Apoptosis in the nervous system. Nature 2000, 407:802\u2013809.","journal-title":"Nature"},{"key":"7_CR6","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0006-291X(86)90708-4","volume":"140","author":"P Westermark","year":"1986","unstructured":"Westermark P, Wernstedt C, Wilander E, et al.: A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 1986, 140:827\u2013831.","journal-title":"Biochem Biophys Res Commun"},{"key":"7_CR7","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","volume":"84","author":"P Westermark","year":"1987","unstructured":"Westermark P, Wernstedt C, Wilander E, et al.: Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci U S A 1987, 84:3881\u20133885.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR8","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","volume":"84","author":"GJ Cooper","year":"1987","unstructured":"Cooper GJ, Willis AC, Clark A, et al.: Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A 1987, 84:8628\u20138632.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR9","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2337\/diabetes.50.3.534","volume":"50","author":"J Wang","year":"2001","unstructured":"Wang J, Xu J, Finnerty J, et al.: The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal cleavage site. Diabetes 2001, 50:534\u2013539.","journal-title":"Diabetes"},{"key":"7_CR10","doi-asserted-by":"crossref","first-page":"8822","DOI":"10.1073\/pnas.89.18.8822","volume":"89","author":"SP Smeekens","year":"1992","unstructured":"Smeekens SP, Montag Ag, Thomas G, et al.: Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3. Proc Natl Acad Sci U S A 1992, 89:8822\u20138826.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR11","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/BF00296991","volume":"30","author":"WK Ward","year":"1987","unstructured":"Ward WK, LaCava EC, Paquette TL, et al.: Disproportionate elevation of immunoreactive proinsulin in type 2 (noninsulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 1987, 30:698\u2013702.","journal-title":"Diabetologia"},{"key":"7_CR12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0014-5793(95)01512-4","volume":"379","author":"P Westermark","year":"1996","unstructured":"Westermark P, Li ZC, Westermark GT, et al.: Effects of beta cell granule components on human islet amyloid polypeptide fibril formation. FEBS Lett 1996, 379:203\u2013206.","journal-title":"FEBS Lett"},{"key":"7_CR13","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1006\/bbrc.1997.7014","volume":"236","author":"S Janciauskiene","year":"1997","unstructured":"Janciauskiene S, Eriksson S, Carlemalm E, Ahr\u00e9n B: B cell granule peptides affect human islet amyloid polypeptide (IAPP) fibril formation in vitro. Biochem Biophys Res Commun 1997, 236:580\u2013585.","journal-title":"Biochem Biophys Res Commun"},{"key":"7_CR14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0925-4439(01)00078-3","volume":"1537","author":"ET Jaikaran","year":"2001","unstructured":"Jaikaran ET, Clark A: Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology. Biochim Biophys Acta 2001, 1537:179\u2013203.","journal-title":"Biochim Biophys Acta"},{"key":"7_CR15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/13506129409148624","volume":"1","author":"P Westermark","year":"1994","unstructured":"Westermark P: Amyloid and polypeptide hormones: what is their inter-relationship? Amyloid 1994, 1:47\u201360.","journal-title":"Amyloid"},{"key":"7_CR16","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","volume":"87","author":"P Westermark","year":"1990","unstructured":"Westermark P, Engstr\u00f6m U, Johnson KH, et al.: Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci U S A 1990, 87:5036\u20135040.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00401195","volume":"35","author":"P Westermark","year":"1992","unstructured":"Westermark P, Johnson KH, O'Brien TD, Betsholtz C: Islet amyloid polypeptide-a novel controversy in diabetes research. Diabetologia 1992, 35:297\u2013303.","journal-title":"Diabetologia"},{"key":"7_CR18","first-page":"291","volume":"81","author":"P Westermark","year":"1973","unstructured":"Westermark P, Grimelius L: The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults. Acta Pathol Microbiol Scand [A] 1973, 81:291\u2013300.","journal-title":"Acta Pathol Microbiol Scand [A]"},{"key":"7_CR19","first-page":"151","volume":"9","author":"A Clark","year":"1988","unstructured":"Clark A, Wells CA, Buley ID, et al.: Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 1988, 9:151\u2013159.","journal-title":"Diabetes Res"},{"key":"7_CR20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","volume":"52","author":"AE Butler","year":"2003","unstructured":"Butler AE, Janson J, Bonner-Weir S, et al.: Beta-cell deficit and increase beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003, 52:102\u2013110.","journal-title":"Diabetes"},{"key":"7_CR21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF00452067","volume":"29","author":"CFJ Howard","year":"1986","unstructured":"Howard CFJ: Longitudinal studies on the development of diabetes in individual Macaca nigra. Diabetologia 1986, 29:301\u2013306.","journal-title":"Diabetologia"},{"key":"7_CR22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJM198907063210102","volume":"321","author":"KH Johnson","year":"1989","unstructured":"Johnson KH, O'Brien TD, Betsholtz C, Westermark P: Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus. N Engl J Med 1989, 321:513\u2013518.","journal-title":"N Engl J Med"},{"key":"7_CR23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s001250051175","volume":"42","author":"JWM H\u00f6ppener","year":"1999","unstructured":"H\u00f6ppener JWM, Oosterwijk C, Nieuwenhuis MG, et al.: Extensive islet amyloid formation is induced by development of type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model. Diabetologia 1999, 42:427\u2013434.","journal-title":"Diabetologia"},{"key":"7_CR24","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1073\/pnas.93.8.3492","volume":"93","author":"CB Verchere","year":"1996","unstructured":"Verchere CB, D'Alessio DA, Palmiter RD, et al.: Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci U S A 1996, 93:3492\u20133496.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR25","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/BF03402051","volume":"6","author":"GT Westermark","year":"2000","unstructured":"Westermark GT, Gebre-Medhin S, Steiner DF, Westermark P: Islet amyloid development in a mouse strain lacking endogenous islet amyloid polypeptide (IAPP) but expressing human IAPP. Mol Med 2000, 6:998\u20131007.","journal-title":"Mol Med"},{"key":"7_CR26","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.2337\/diabetes.52.9.2304","volume":"52","author":"AE Butler","year":"2003","unstructured":"Butler AE, Janson J, Soeller WC, Butler PC: Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 2003, 52:2304\u20132314.","journal-title":"Diabetes"},{"key":"7_CR27","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/diabetes.53.6.1509","volume":"53","author":"AE Butler","year":"2004","unstructured":"Butler AE, Jang J, Gurlo T, et al.: Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes. Diabetes 2004, 53:1509\u20131516.","journal-title":"Diabetes"},{"key":"7_CR28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3109\/13506120108993820","volume":"8","author":"Z Ma","year":"2001","unstructured":"Ma Z, Westermark GT, Sakagashira S, et al.: Enhanced in vitro production of amyloid-like fibrils from mutant (S20G) islet amyloid polypeptide. Amyloid 2001, 8:242\u2013249.","journal-title":"Amyloid"},{"key":"7_CR29","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2337\/diab.45.9.1279","volume":"45","author":"S Sakagashira","year":"1996","unstructured":"Sakagashira S, Sanke T, Hanabusa T, et al.: Missense mutation of amylin gene (S20G) in Japanese NIDDM patients. Diabetes 1996, 45:1279\u20131281.","journal-title":"Diabetes"},{"key":"7_CR30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2337\/diab.43.2.329","volume":"43","author":"TD O'Brien","year":"1994","unstructured":"O'Brien TD, Butler AE, Roche PC, et al.: Islet amyloid polypeptide in human insulinomas. Evidence for intracellular amyloidogenesis. Diabetes 1994, 43:329\u2013336.","journal-title":"Diabetes"},{"key":"7_CR31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1517\/03009734000000057","volume":"105","author":"GT Westermark","year":"2000","unstructured":"Westermark GT, Steiner DF, Gebre-Medhin S, et al.: Pro islet amyloid polypeptide (proIAPP) immunoreactivity in amyloid formation in the islets of Langerhans. Upsala J Med Sci 2000, 105:97\u2013106.","journal-title":"Upsala J Med Sci"},{"key":"7_CR32","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF00400722","volume":"38","author":"P Westermark","year":"1995","unstructured":"Westermark P, Eizirik DL, Pipeleers DG, et al.: Rapid deposition of amyloid in human islets transplanted into nude mice. Diabetologia 1995, 38:543\u2013549.","journal-title":"Diabetologia"},{"key":"7_CR33","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0026-0495(99)90102-6","volume":"48","author":"GT Westermark","year":"1999","unstructured":"Westermark GT, Westermark P, Eizirik D, et al.: Differences in amyloid deposition in islets of transgenic mice expressing human islet amyloid polypeptide versus human islets implanted into nude mice. Metabolism 1999, 48:448\u2013454.","journal-title":"Metabolism"},{"key":"7_CR34","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM200007273430401","volume":"343","author":"AMJ Shapiro","year":"2000","unstructured":"Shapiro AMJ, Lakey JRT, Ryan EA, et al.: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid free immunosuppressive regiment. N Engl J Med 2000, 343:230\u2013238.","journal-title":"N Engl J Med"},{"key":"7_CR35","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.2337\/diabetes.51.7.2148","volume":"51","author":"EA Ryan","year":"2002","unstructured":"Ryan EA, Lakey JRT, Paty BW, et al.: Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002, 51:2148\u20132157.","journal-title":"Diabetes"},{"key":"7_CR36","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.2337\/diabetes.53.12.3107","volume":"53","author":"CN Street","year":"2004","unstructured":"Street CN, Lakey JRT, Shapiro AMJ, et al.: Islet graft assessment in the Edmonton Protocol. Implications for predicting long-term clinical outcome. Diabetes 2004, 53:3107\u20133114. Summarizes the present knowledge about clinical islet transplantation.","journal-title":"Diabetes"},{"key":"7_CR37","doi-asserted-by":"crossref","first-page":"9253","DOI":"10.1073\/pnas.91.20.9253","volume":"91","author":"DL Eizirik","year":"1994","unstructured":"Eizirik DL, Pipeleers DG, Ling Z, et al.: Major species differences between man and rodents in the susceptibility to pancreatic beta-cell injury. Proc Natl Acad Sci U S A 1994, 91:9253\u20139256.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/2000-1967-113","volume":"108","author":"GT Westermark","year":"2003","unstructured":"Westermark GT, Westermark P, Nordin A, et al.: Formation of amyloid in human pancreatic islets transplanted to the liver and spleen of nude mice. Upsala J Med Sci 2003, 108:193\u2013204. One of few articles dealing with the putative role of IAPP aggregation for human islet transplant failure.","journal-title":"Upsala J Med Sci"},{"key":"7_CR39","first-page":"A375","volume":"53","author":"K Kodama","year":"2004","unstructured":"Kodama K, Hull RL, Wildbur S, et al.: Amyloid formation following islet transplantation is associated with increased beta-cell apoptosis, decreased beta-cell replication and reduced beta-cell volume [abstract]. Diabetes 2004, 53:A375-A376.","journal-title":"Diabetes"},{"key":"7_CR40","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/BF03401591","volume":"1","author":"G Westermark","year":"1995","unstructured":"Westermark G, Benig Arora M, Fox N, et al.: Amyloid formation in response to beta cell stress occurs in vitro, but not in vivo, in islets of transgenic mice expressing human islet amyloid polypeptide. Mol Med 1995, 1:542\u2013543.","journal-title":"Mol Med"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-005-0007-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11892-005-0007-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-005-0007-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:56:13Z","timestamp":1559433373000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11892-005-0007-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["7"],"URL":"https:\/\/doi.org\/10.1007\/s11892-005-0007-2","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}